# Bioequivalence Study of Levothyroxine Sodium Tablets 150 mcg

> **NCT03634371** · PHASE4 · UNKNOWN · sponsor: **Tecnoquimicas** · enrollment: 80 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Drug Levothyroxine 150 mcg
- **DRUG:** Drug Eutirox 150 mcg

## Key facts

- **NCT ID:** NCT03634371
- **Lead sponsor:** Tecnoquimicas
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-10
- **Primary completion:** 2018-10-06
- **Final completion:** 2018-10-06
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2018-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03634371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03634371, "Bioequivalence Study of Levothyroxine Sodium Tablets 150 mcg". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03634371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*